Over decades, the classification of BC has been changed progressively based on a list of criteria such as tumor grade, tumor size, histological types, lymph node status, hormone receptors, and gene expression, and helped in recognizing prognosis variability and predicting clinical outcomes [2,3,4]. Here, NR4A1 is linked to neoplasm.